Research Article

Stem cell therapy in children with acute liver failure: The dream could come true

Riham Rabie Issa*, Ahmad Mohamed Sira and Mostafa Mohamed Sira

Published: 01/11/2021 | Volume 5 - Issue 1 | Pages: 001--004

Abstract

Acute liver failure (ALF) in children is a severe disease with a high mortality rate. The current treatment strategies are still defective, with many cases die when liver transplantation is unavailable. The current protocol of steroids therapy improved the survival rate of hepatitis A virus (HAV)-related ALF. However, there is still a high mortality for non-HAV cases. Stem cell therapy (SCT) has been tried in experimental animals with ALF and in few adult studies with acute-on-chronic liver failure. No previous trials of SCT have been tested in children with ALF. The absence of SCT application in ALF in children could be due to some issues. These could be related to safety, sources, administration route, optimum dosage, efficacy, and survival. It is proposed that could be the future therapy if these obstacles have been well studied and solved.

Read Full Article HTML DOI: 10.29328/journal.acgh.1001024 Cite this Article

References

  1. Zakaria HM, Salem TA, El-Araby HA, Salama RM, Elbadry DY, et al. Steroid therapy in children with fulminant hepatitis A. J Viral Hepat. 2018; 25: 853-859. PubMed: https://pubmed.ncbi.nlm.nih.gov/29397017/
  2. Robert H. Squires, Alonso EM. Acute liver failure in children. In: Frederick J. Suchy, Ronald J. Sokol, Balistreri WF, editors. Liver Disease in Children. United Kingdom Bell and Bain Ltd. 2014; 32-50.
  3. Zhang S, Yang Y, Fan L, Zhang F, Li L. The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future. Ann Transl Med. 2020; 8: 565. PubMed: https://pubmed.ncbi.nlm.nih.gov/32775366/
  4. Majhail NS, Farnia SH, Carpenter PA, Champlin RE, Crawford S, et al. Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation. Biology of blood and marrow transplantation. Biol Blood Marrow Transplant. 2015; 21: 1863-1869. PubMed: https://pubmed.ncbi.nlm.nih.gov/26256941/
  5. Sureda A, Bader P, Cesaro S, Dreger P, Duarte RF, et al. Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015. Bone Marrow Transplant. 2015; 50: 1037-1056. PubMed: https://pubmed.ncbi.nlm.nih.gov/25798672/
  6. Tan EY, Boelens JJ, Jones SA, Wynn RF. Hematopoietic Stem Cell Transplantation in Inborn Errors of Metabolism. Front Pediatr. 2019; 7: 433. PubMed: https://pubmed.ncbi.nlm.nih.gov/31709204/
  7. Wachowiak J, Labopin M, Miano M, Chybicka A, Stary J, et al. Haematopoietic stem cell transplantation in children in eastern European countries 1985-2004: development, recent activity and role of the EBMT/ESH Outreach Programme. Bone Marrow Transplant. 2008; 41: S112-117. PubMed: https://pubmed.ncbi.nlm.nih.gov/18545232/
  8. de Miguel MP, Prieto I, Moratilla A, Arias J, Aller M. Mesenchymal stem cells for liver regeneration in liver failure: from experimental models to clinical trials. Stem Cells Int. 2019; 2019.
  9. Adiwinata Pawitan J. Exploring the most promising stem cell therapy in liver failure: a systematic review. Stem Cells Int. 2019; 2019.
  10. Yuan S, Jiang T, Sun L, Zheng R, Ahat N, et al. The role of bone marrow mesenchymal stem cells in the treatment of acute liver failure. BioMed Res Int. 2013; 2013: 251846. PubMed: https://pubmed.ncbi.nlm.nih.gov/24312909/
  11. Zheng S, Yang J, Tang Y, Shao Q, Guo L, Liu Q. Transplantation of umbilical cord mesenchymal stem cells via different routes in rats with acute liver failure. Int J Clin Exp Pathol. 2015; 8: 15854-15862. PubMed: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730069/
  12. Huang B, Cheng X, Wang H, Huang W, la Ga Hu Z, et al. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. J Transl Med. 2016; 14: 45. PubMed: https://pubmed.ncbi.nlm.nih.gov/26861623/
  13. Shi M, Zhang Z, Xu R, Lin H, Fu J, et al. Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med. 2012; 1: 725-731. PubMed: https://pubmed.ncbi.nlm.nih.gov/23197664/
  14. Li YH, Xu Y, Wu HM, Yang J, Yang LH, et al. Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation in Hepatitis B Virus Related Acute-on-Chronic Liver Failure Treated with Plasma Exchange and Entecavir: a 24-Month Prospective Study. Stem Cell Rev Rep. 2016; 12: 645-653. PubMed: https://pubmed.ncbi.nlm.nih.gov/27687792/
  15. Lin BL, Chen JF, Qiu WH, Wang KW, Xie DY, et al. Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: A randomized controlled trial. Hepatology. 2017; 66: 209-219. PubMed: https://pubmed.ncbi.nlm.nih.gov/28370357/
  16. Zhong YS, Lin N, Deng MH, Zhang FC, Tang ZF, et al. Deficient proliferation of bone marrow-derived mesenchymal stem cells in patients with chronic hepatitis B viral infections and cirrhosis of the liver. Dig Dis Sci. 2010; 55: 438-445. PubMed: https://pubmed.ncbi.nlm.nih.gov/19242797/
  17. Tang XP, Zhang M, Yang X, Chen LM, Zeng Y. Differentiation of human umbilical cord blood stem cells into hepatocytes in vivo and in vitro. World J Gastroenterol. 2006; 12: 4014. PubMed: https://pubmed.ncbi.nlm.nih.gov/16810750/
  18. Lorenzini S, Isidori A, Catani L, Gramenzi A, Talarico S, et al. Stem cell mobilization and collection in patients with liver cirrhosis. Aliment Pharmacol Ther. 2008; 27: 932-939. PubMed: https://pubmed.ncbi.nlm.nih.gov/18315586/
  19. Lo B, Parham L. Ethical issues in stem cell research. Endocr Rev. 2009; 30: 204-213. PubMed: https://pubmed.ncbi.nlm.nih.gov/19366754/
  20. Amer MEM, El-Sayed SZ, Abou El-Kheir W, Gabr H, Gomaa AA, et al. Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells. Eur J Gastroenterol Hepatol. 2011; 23: 936-941. PubMed: https://pubmed.ncbi.nlm.nih.gov/21900788/
  21. El-Ansary M, Mogawer S, Abdel-Aziz I, Abdel-Hamid S. Phase I Trial: Mesenchymal Stem Cells Transplantation in End Stage Liver Disease. J Am Sci. 2010; 6: 135-144.
  22. Galipeau J, Sensébé L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018; 22: 824-833. PubMed: https://pubmed.ncbi.nlm.nih.gov/29859173/
  23. Kim JK, Kim SJ, Kim Y, Chung YE, Park YN, et al. Long-term follow-up of patients after autologous bone marrow cell infusion for decompensated liver cirrhosis. Cell Transplant. 2017; 26: 1059-1066. PubMed: https://pubmed.ncbi.nlm.nih.gov/28120743/
  24. Kang SH, Kim MY, Eom YW, Baik SK. Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives. Gut Liver. 2020; 14: 306. PubMed: https://pubmed.ncbi.nlm.nih.gov/31581387/
  25. Peng L, Xie Dy, Lin BL, Liu J, Zhu Hp, et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short term and long term outcomes. Hepatology. 2011; 54: 820-828. PubMed: https://pubmed.ncbi.nlm.nih.gov/21608000/